AMAN MEHTA TORRENT PHARMA
Banking stocks lead markets to four-month high ahead of Diwali
Indian stock markets saw their best weekly performance in four months. Banking stocks led the rally, fueled by positive business updates and loan growth. Investors are optimistic ahead of the Diwali trading session. While short-term gains are expected, analysts suggest caution post-Diwali as loan growth may not sustain. Foreign investors showed buying interest.
Roche Vs Natco: Supreme Court clears decks for launch of Natco Pharma's Risdiplam generic in India
The Supreme Court has allowed Natco Pharma to launch its generic version of the spinal muscular atrophy drug Risdiplam in India, dismissing F. Hoffmann-La Roche's appeal. The court upheld the Delhi High Court's decision, which prioritized public access to the life-saving medication at a significantly lower price.
EKA Mobility Secures ₹500 crore from NIIF’s IJF
The India-Japan Fund has committed ₹500 crore to EKA Mobility, marking a pivotal investment in India's burgeoning electric vehicle industry. With this funding, EKA Mobility is set to enhance its electric bus manufacturing capabilities by establishing a state-of-the-art plant in Pithampur.
Encroachment of lands acquired for Rajasthan Housing Board 'absolute rank scam': SC
The Supreme Court has labelled the encroachment of Rajasthan Housing Board lands an "absolute rank scam," alleging connivance from top to bottom. Justices noted numerous High Court orders against regularizing illegal constructions. The bench expressed strong disapproval while hearing the state's plea, warning of demolition if necessary.
Attack on CJI: AG nod for contempt action; SC says let incident die a natural death
Amidst the aftermath of an unsettling shoe-throwing event directed at Chief Justice of India BR Gavai, the Supreme Court has taken a stance urging a swift resolution. Justices Surya Kant and Joymalya Bagchi recommended letting the controversy die down on its own, as discussions surrounding criminal contempt charges against the lawyer were brought to the forefront.
Shoe throwing incident: AG grants consent to initiate contempt action against lawyer
The Attorney General has consented to contempt action against advocate Rakesh Kishore for hurling a shoe at Chief Justice of India B R Gavai. The Supreme Court Bar Association highlighted social media's demeaning comments, prompting the court to emphasize that free speech is not absolute and cannot compromise institutional dignity. The court acknowledged the ill-effects of unregulated social media.
- Go To Page 1
Torrent Pharma plans Rs 14,000 crore bond sale for JB Chemicals acquisition
Torrent Pharmaceuticals is planning a ₹14,000-crore bond sale to finance its acquisition of JB Chemicals & Pharmaceuticals. The company is in discussions with major banks for the funding package, which will be repaid through internal accruals. The proposed merger is awaiting regulatory approvals.
Under the scanner, yet generic cough syrups hit shelves
Worry is spreading regarding the multitude of cough syrup brands circulating in India, with alarming revelations of toxic diethylene glycol detected in some, resulting in heartbreaking instances of child mortality. This situation sheds light on the questionable efficacy of regulatory measures, as many small-scale producers evade scrutiny.
Sonam Wangchuk's release plea to be amended after centre's reply
Sonam Wangchuk's wife has taken steps to revise her Supreme Court appeal against her husband's detention, as the Centre has recently laid out its rationale for his confinement. The court has agreed to her amendments and will take up the case once more.
JDU names 57 candidates, gives tickets to just 4 women
In a significant move ahead of the Bihar elections, the JDU has released its first roster of 57 hopefuls. Among them, 18 incumbents have secured their spots, while four have been dropped from the lineup. The slate includes a commendable representation with four women and ten candidates from the Scheduled Castes, yet it notably lacks any representation for Muslim candidates.
Dipan Mehta bullish on LG Electronics as GST cut boosts outlook
Market expert Dipan Mehta highlights selective opportunities in the IT sector, favoring new-generation companies like Persistent Systems over traditional players. He is positive on LG Electronics due to strong consumer sales and GST cuts. Mehta maintains a neutral stance on insurance but is very optimistic about the healthcare diagnostics sector, citing strong recent results and secular growth trends.
Roche moves SC against Natco’s launch of generic Risdiplam in India
F. Hoffmann-La Roche AG has approached the Supreme Court. This follows a Delhi High Court decision permitting Natco Pharma to introduce a generic version of Risdiplam. Risdiplam treats spinal muscular atrophy. The High Court rejected Roche's plea to halt Natco's manufacturing. Natco plans to sell the drug at a significantly lower price.
Nifty faces selling pressure; Torrent Power, REC among top picks
Indian equity markets experienced selling pressure on Tuesday, with midcap and smallcap stocks showing particular weakness. While the Nifty remains in an overall bullish trend above key moving averages, intraday signs are negative. The upcoming results season is expected to increase market choppiness, emphasizing the need for risk management and focus on outperforming sectors.
Bengaluru tops Hurun India under-35 list with 54 young entrepreneurs, Mumbai and Delhi follow
Bengaluru leads the Avendus Wealth – Hurun India U35 List 2025 with 54 young entrepreneurs, highlighting its dominance in technology and innovation. The list features 155 rising leaders nationwide, showcasing a new generation of builders and disruptors shaping India's business landscape.
India accuses Balaji Amines of making pharma-grade chemical without a drug-making licence
Balaji Amines faces accusations from Indian authorities for producing pharma-grade propylene glycol without a necessary drug manufacturing license. This comes after some batches were found to be substandard. The company states it only manufactured technical and food-grade PG for non-pharma clients. Investigations are ongoing, and the company's stock has seen a decline.
With the tariff threat headache over, time to focus on them again? 8 pharma stocks with upside potential of up to 39%
With a clear indication that no additional or special tariff will be imposed by the US on generic drugs, there is a sense of relief among Indian drug companies. The US healthcare system, too, must be relieved, given that India is the biggest supplier of generic drugs to the American market. Any increase in the cost of these medicines would have led to a disruption in the US healthcare system. Now that the tariff threat – which has been troubling Indian companies for the past year – is seemingly a thing of the past, will things get better on the street for Indian pharma companies?
Who was Abhishek Bachchan’s first love? She was one of Bollywood’s first glamour girls
Abhishek Bachchan once humorously recalled asking Zeenat Aman if he could sleep with her as a child, to which she advised him to grow up. The article also delves into Zeenat Aman's personal life, detailing her marriages and her later reflections on an unfulfilling union with Mazhar Khan.
Cough syrup deaths: Sresan Pharma owner Ranganathan sent to 10-day police custody
A Madhya Pradesh court has remanded Sresan Pharma owner Ranganathan to 10-day police custody following alleged child deaths linked to Coldrif cough syrup. Meanwhile, the Supreme Court dismissed a PIL seeking drug safety reforms, with the Solicitor General arguing states are already taking action and have enforcement mechanisms.
Supreme Court reserves verdict as NCR proposes time limits for bursting green crackers on Diwali
The Supreme Court has reserved its decision on pleas to allow green firecracker manufacturing and sales in Delhi-NCR. Solicitor General Tushar Mehta proposed specific time slots for festivals like Diwali, Christmas, and Gurpurab, emphasizing NEERI-approved green crackers and licensed traders. The court previously allowed green cracker production but restricted sales in NCR without prior approval.
India proposes to open up power retail sector to private cos, draft bill shows
The move will allow private companies such as Adani Power, Tata Power, Torrent Power and CESC to strengthen their presence in the country.
Over Rs 5.5 lakh crore push thermal power plans get all charged up
India's top power companies are set to invest over Rs 5.5 lakh crore to boost thermal power capacity by more than 50 GW by 2032. This expansion runs parallel to their ongoing investments in renewable energy sources. The move aims to meet soaring electricity demand and ensure grid stability.
Indian states sign more coal power deals to meet rising demand
Indian states are signing new long-term deals for coal power. This is to meet rising evening electricity demand. This comes as clean energy capacity grows. States like Uttar Pradesh and Assam are seeking new coal power contracts. This trend is expected to slow India's decarbonisation efforts. New coal power investments are being made. Battery storage is still developing slowly.
IPO-bound Boat turns around, posts Rs 60 crore profit
IPO-bound Boat posted a net profit of over Rs 60 crore in FY25, a significant turnaround from last year's loss, driven by product innovation and cost control. Despite a slight revenue dip, the company achieved Rs 142 crore EBITDA and received SEBI's nod for its IPO, reflecting its resilient business model and local manufacturing push.
Stocks in news: HDFC Bank, DMart, Vedanta, Tata Steel, Bajaj Finance, Vodafone Idea
Markets closed higher on Friday, with Nifty testing key resistance at 24,900. Analysts predict further recovery if this level is breached. Several companies are in focus today. HDFC Bank reported loan growth. DMart and Bajaj Housing Finance showed strong revenue and disbursement gains. Vedanta pushed its demerger deadline. Tata Steel received a demand letter. Bajaj Finance saw AUM jump.
Torrent Pharma gets demand notices totalling Rs 6.63 cr from NPPA
Torrent Pharmaceuticals reported receiving demand notices from the NPPA. The notices total over Rs 6.63 crore. They allege overcharging for five drugs between January 2016 and November 2018. The company stated these notices were received on October 3, 2025. Torrent Pharmaceuticals expects no material financial impact from this development.
Indian Pharmaceutical Alliance appoints Zydus Lifesciences MD Sharvil Patel as new president
The Indian Pharmaceutical Alliance (IPA) has appointed Sharvil Patel of Zydus Lifesciences as its new President, with Glenn Saldanha of Glenmark as Vice President. This leadership transition occurs as the industry navigates GST reforms and strengthens its global position in specialty medicines. The new team aims to drive innovation, patient access, and quality healthcare solutions.
IPA names Zydus Lifesciences MD Sharvil Patel as President
Sharvil Patel is the new president of the Indian Pharmaceutical Alliance. He takes over from Samir Mehta. Glenn Saldanha becomes the vice president. The IPA represents 23 national pharmaceutical companies. The new team will build on reforms and breakthroughs. They will focus on innovation, patient access, and quality in healthcare.
Load More
